CLINICAL_TRIALS
trial_result
· 2021-05-19
Clinical Trial Update: Eluxadoline Bile Acid Malabsorption (BAM) Study [Phase 4]
Summary
Phase 4 trial update for eluxadoline in bile acid malabsorption related to irritable bowel syndrome with diarrhea has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allergan | Conditions: Irritable Bowel Syndrome With Diarrhea | Phase 4 | Status: COMPLETED | Results posted: 2021-05-19